Clinical Investigative Site Network Market

Direct contracting is projected to represent 47.0% of distribution channel in 2026 while pharmaceutical companies account for 42.0% of end user. Sponsors adopt coordinated networks to improve multicenter enrollment and site oversight but investigator shortages and uneven local performance can weaken delivery.